ES2183223T3 - Composicion para uso veterinario intramamaria que no contiene agentes antiinflamatorios. - Google Patents

Composicion para uso veterinario intramamaria que no contiene agentes antiinflamatorios.

Info

Publication number
ES2183223T3
ES2183223T3 ES97949079T ES97949079T ES2183223T3 ES 2183223 T3 ES2183223 T3 ES 2183223T3 ES 97949079 T ES97949079 T ES 97949079T ES 97949079 T ES97949079 T ES 97949079T ES 2183223 T3 ES2183223 T3 ES 2183223T3
Authority
ES
Spain
Prior art keywords
intramamary
composition
inflammatory agents
veterinary use
contain anti
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97949079T
Other languages
English (en)
Other versions
ES2183223T5 (es
Inventor
Vincent Mcnally
James Patrick Morgan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zoetis Broomhill IP Ltd
Original Assignee
Bimeda Research and Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11041329&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2183223(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bimeda Research and Development Ltd filed Critical Bimeda Research and Development Ltd
Publication of ES2183223T3 publication Critical patent/ES2183223T3/es
Application granted granted Critical
Publication of ES2183223T5 publication Critical patent/ES2183223T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01J—MANUFACTURE OF DAIRY PRODUCTS
    • A01J7/00—Accessories for milking machines or devices
    • A01J7/04—Accessories for milking machines or devices for treatment of udders or teats, e.g. for cleaning
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Husbandry (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Environmental Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Food Science & Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una formulación exenta de agentes antiinflamatorios para el tratamiento preventivo de mastitis en vacas secas que comprende una formulación de sellado que tiene aproximadamente un 65% en peso de un subnitrato de bismuto en un gel a base de estearato de aluminio. Una formulación exenta de agentes antiinflamatorios para el tratamiento preventivo de mastitis en vacas secas. La formulación de sellado se prepara añadiendo el subnitrato de bismuto a la base del gel en al menos dos etapas separadas.
ES97949079.4T 1996-12-18 1997-12-17 Composición intramamaria para uso veterinario que no contiene agentes antiinflamatorios Expired - Lifetime ES2183223T5 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IE960896 1996-12-18
IE960896 1996-12-18
PCT/IE1997/000085 WO1998026759A1 (en) 1996-12-18 1997-12-17 Antiinfective free intramammary veterinary composition

Publications (2)

Publication Number Publication Date
ES2183223T3 true ES2183223T3 (es) 2003-03-16
ES2183223T5 ES2183223T5 (es) 2015-05-07

Family

ID=11041329

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97949079.4T Expired - Lifetime ES2183223T5 (es) 1996-12-18 1997-12-17 Composición intramamaria para uso veterinario que no contiene agentes antiinflamatorios

Country Status (16)

Country Link
US (9) US6254881B1 (es)
EP (1) EP0971690B2 (es)
JP (1) JP4328886B2 (es)
AT (1) ATE223201T1 (es)
AU (1) AU724518B2 (es)
BR (1) BR9714935A (es)
CA (1) CA2274796C (es)
DE (1) DE69715259T3 (es)
DK (1) DK0971690T4 (es)
ES (1) ES2183223T5 (es)
GB (1) GB2334886B (es)
IE (1) IE970892A1 (es)
NZ (1) NZ336153A (es)
PT (1) PT971690E (es)
WO (1) WO1998026759A1 (es)
ZA (1) ZA9711362B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0971690B2 (en) * 1996-12-18 2015-04-01 Bimeda Research & Development Limited Antiinfective free intramammary veterinary composition
US20030060414A1 (en) * 2001-09-10 2003-03-27 Mchardy Nicholas Bio-security system
SE524623C2 (sv) * 2002-08-08 2004-09-07 Bofors Defence Ab Isolerad patronhylsa och ammunition, förfarande för tillverkning av dylika hylsor och ammunition samt användning av dylika hylsor och ammunition vid flera skilda vapensystem
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
US20040197422A1 (en) * 2002-12-20 2004-10-07 Pfizer Inc Veterinary compositions for treating mastitis
GB0229642D0 (en) * 2002-12-20 2003-01-22 Pfizer Ltd Veterinary compositions for treating mastitis
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
NZ548748A (en) 2004-02-02 2010-09-30 Bimeda Res & Dev Ltd Method and device for treating a teat canal of an animal
GB2429159C (en) 2004-02-02 2016-07-06 Bimeda Res & Dev Ltd Method and device for treating a teat canal of an animal
US20050191270A1 (en) * 2004-02-27 2005-09-01 Hydromer, Inc. Anti-infectious hydrogel compositions
PT1931346E (pt) * 2005-09-09 2012-08-14 Angelini Labopharm Llc Composição de trazodona para administração uma vez por dia
WO2007048219A2 (en) * 2005-09-09 2007-05-03 Labopharm Inc. Sustained drug release composition
AU2013202381B2 (en) * 2006-10-10 2016-05-05 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
MX2009003924A (es) * 2006-10-10 2009-11-10 Wisconsin Alumni Res Found Formulacion selladora intra-mamaria para el pezon y metodo para utilizar la misma para reducir o eliminar los defectos visuales en quesos añejos.
NZ571347A (en) 2008-09-17 2010-04-30 Mastitis Res Ct Ltd Anti-infective formulation and methods of use
AU2015202929B2 (en) * 2008-09-17 2017-08-17 Elanco New Zealand Anti-infective formulation and methods of use
EP2376196A4 (en) * 2008-11-28 2012-05-30 Mastitis Res Ct Ltd ANIMAL TREATMENT FORMULATION AND METHODS OF USE
US20100143510A1 (en) * 2008-12-04 2010-06-10 Majid Razzak Intramammary teat sealant
WO2010118142A1 (en) * 2009-04-08 2010-10-14 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
JP6514211B2 (ja) 2013-09-16 2019-05-15 ゾエティス・サービシーズ・エルエルシー 薬物を連続して送達するためのアセンブリ及び関連方法
EP3285661B1 (en) 2015-04-24 2021-04-14 Sanuwave, Inc. Tissue disinfection with acoustic pressure shock waves
AU2016345400B2 (en) 2015-10-29 2021-10-14 Zoetis Broomhill Ip Limited A teat seal formulation
RU2761212C2 (ru) 2015-11-03 2021-12-06 Зоэтис Сервисиз Ллс Полимерные композиты, полученные по способу золь-гель, и их применение
US11446324B2 (en) 2017-04-20 2022-09-20 Zoetis Services Llc Veterinary compositions for use in treating mastitis, and associated methods
BR112019025855A2 (pt) 2017-06-09 2020-07-14 Zoetis Broomhill Ip Limited composição veterinária intramamária
WO2019108747A1 (en) 2017-12-01 2019-06-06 Zoetis Services Llc Hydrogel compositions and uses thereof
WO2019141771A1 (en) * 2018-01-18 2019-07-25 Zoetis Broomhill Ip Limited Internal teat sealants and their use in the prevention of bovine mastitis in the dry cow
EP3513767A1 (en) * 2018-01-18 2019-07-24 Bimeda Research & Development Limited Internal teat sealants and their use in the prevention of bovine mastitis in the dry cow
GR1010072B (el) 2019-05-15 2021-09-15 Αριστοτελειο Πανεπιστημιο Θεσσαλονικης - Ειδικος Λογαριασμος Κονδυλιων Ερευνας Βρωσιμα κτηνιατρικα σκευασματα ενδομαστικης προστασιας θηλαστικων και μεθοδος για την παρασκευη τους
US20240382647A1 (en) 2023-05-18 2024-11-21 Filid Tecnologia Farmacêutica Ltda (ME) Method for Preparing an Intramammary Teat Sealing Composition and Sealing Composition Obtained By Such Process

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB792545A (en) 1955-07-27 1958-03-26 Novo Terapeutisk Labor As Manufacture of antibiotic preparations having a protracted effect
US3222252A (en) 1962-11-01 1965-12-07 Heinz J Kraus Preparation and method for the prevention, treatment, and control of mastitis in bovine udders
GB1312918A (en) 1969-07-08 1973-04-11 Beecham Group Ltd Veterinary treatment
GB1441747A (en) * 1972-10-18 1976-07-07 Lazonby B Veterinary compositions
GB1455296A (en) * 1973-05-24 1976-11-10 Beecham Group Ltd Veterinary treatment
CA1052697A (en) 1974-03-29 1979-04-17 Upjohn Company (The) Composition for treating mastitis in animals
US4049830A (en) * 1974-11-13 1977-09-20 Milmark Research, Inc. Bovine teat dip
GB1547164A (en) 1975-08-14 1979-06-06 Beecham Group Ltd Veterinary compositions
US4022199A (en) 1975-09-24 1977-05-10 Fetty Walter W Method of preventing the spread and control of mastitis
US4113854A (en) 1977-01-10 1978-09-12 Minnesota Mining And Manufacturing Company Prophylactic treatment of mastitis
US4172138A (en) * 1977-03-23 1979-10-23 Rhodes Russell E Method and composition of matter for the treatment of dry cows for mastitis
IE49768B1 (en) 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
US4344967A (en) * 1979-08-07 1982-08-17 Devro, Inc. Film forming composition and uses thereof
EP0076068A3 (en) 1981-09-25 1985-05-15 Beecham Group Plc Intramammary veterinary compositions and method for their use
IE53610B1 (en) 1981-12-14 1988-12-21 Merck & Co Inc Waterless thixotropic composition
GB8629481D0 (en) * 1986-12-10 1987-01-21 Beecham Group Plc Veterinary treatment
US5017369A (en) 1987-03-03 1991-05-21 Marhevka Virginia C Film-forming teat sealer for prevention of mastitis and use thereof
US5195966A (en) * 1987-12-24 1993-03-23 Diversey Limited Treatment of mastitis and applicator therefor
US5593384A (en) * 1989-03-23 1997-01-14 Halem; Stephen H. Controlled infusion administration of pharmaceuticals
CA2041774C (en) * 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
JPH0660104B2 (ja) 1990-12-17 1994-08-10 鈴木 忠 乳牛の乳房炎に対する治療剤
RU2028798C1 (ru) 1991-04-08 1995-02-20 Институт животноводства УААН Способ профилактики мастита у коров
WO1995031180A1 (en) 1992-12-08 1995-11-23 Bimeda Research And Development Limited A veterinary composition
GB2273441B (en) * 1992-12-08 1997-01-08 Bimeda Res Dev Ltd Veterinary compositions for treating mastitis
JP3288550B2 (ja) 1994-05-02 2002-06-04 オーバーシーズ ファーマテック株式会社 ヘリコバクター・ピロリ菌殺菌のための局所用口腔内投与剤
US5529770A (en) 1994-12-09 1996-06-25 West Agro, Inc. Viscous liquid conditioning topical germicides
DE19502629C2 (de) 1995-01-19 1998-11-05 Grace Gmbh Verwendung einer Zusammensetzung auf Basis von polyolbehandeltem Siliciumdioxid als Antiblockingmittel
JP4111999B2 (ja) 1995-02-01 2008-07-02 デュラセル、インコーポレーテッド スラリ製造方法
JP3851371B2 (ja) 1995-02-25 2006-11-29 久光製薬株式会社 非水系油性軟膏基剤及び皮膚外用軟膏剤
EP0971690B2 (en) * 1996-12-18 2015-04-01 Bimeda Research & Development Limited Antiinfective free intramammary veterinary composition
US6107344A (en) * 1999-02-16 2000-08-22 Webco Chemical Corporation Aqueous germicidal film forming composition for applying to teats of dairy cows
US20050192547A1 (en) * 2002-01-31 2005-09-01 Modak Shanta M. Combinations of antiseptic and antibiotic agents containing medical devices
US20040197422A1 (en) * 2002-12-20 2004-10-07 Pfizer Inc Veterinary compositions for treating mastitis

Also Published As

Publication number Publication date
AU724518B2 (en) 2000-09-21
US20050175713A1 (en) 2005-08-11
US20170196909A1 (en) 2017-07-13
JP4328886B2 (ja) 2009-09-09
EP0971690B2 (en) 2015-04-01
PT971690E (pt) 2002-12-31
DK0971690T3 (da) 2002-12-23
GB2334886A (en) 1999-09-08
US6506400B1 (en) 2003-01-14
GB9913953D0 (en) 1999-08-18
NZ336153A (en) 2000-06-23
US6254881B1 (en) 2001-07-03
DK0971690T4 (en) 2015-07-13
ZA9711362B (en) 1998-08-28
WO1998026759A1 (en) 1998-06-25
US6340469B1 (en) 2002-01-22
AU7735198A (en) 1998-07-15
US20030235625A1 (en) 2003-12-25
CA2274796A1 (en) 1998-06-25
DE69715259D1 (de) 2002-10-10
DE69715259T2 (de) 2003-08-07
GB2334886B (en) 2000-08-23
ES2183223T5 (es) 2015-05-07
EP0971690A1 (en) 2000-01-19
US20150051300A1 (en) 2015-02-19
US8758831B2 (en) 2014-06-24
US20110268819A1 (en) 2011-11-03
US20100055202A1 (en) 2010-03-04
DE69715259T3 (de) 2015-08-20
IE970892A1 (en) 2000-02-09
EP0971690B1 (en) 2002-09-04
ATE223201T1 (de) 2002-09-15
CA2274796C (en) 2006-12-05
BR9714935A (pt) 2000-10-03
JP2001506648A (ja) 2001-05-22

Similar Documents

Publication Publication Date Title
ES2183223T3 (es) Composicion para uso veterinario intramamaria que no contiene agentes antiinflamatorios.
CA2084730A1 (en) Skin antiseptic and hand disinfectant
AU1666188A (en) Deodorizing and antimicrobial composition for use in cosmetic or topical formulations
EE03293B1 (et) Geel ja selle kasutamine farmatseutilise kompositsiooni valmistamiseks nahahaiguste raviks
MX9705296A (es) Compuestos novedosos de imidazol 1,4,5-susbtituidos y el uso de los mismos para preparar composiciones para uso en terapia.
AU5555086A (en) Azolylmethyloxiranes their preparation and their use as crop protection agents
IT1227154B (it) Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
CA2063576A1 (en) Slow release vehicles for minimizing skin irritancy of topical compositions
YU47204B (sh) Derivati didehidro-vitamina d3
ES2063097T3 (es) Inhibidor de la glicosidasa salbostatina, procedimiento para su preparacion y su empleo.
AU531057B2 (en) 6beta,7beta,15,16-dimethylene-1,4-androstadien-3-ones
MX9204637A (es) Nuevos derivados de pirazina y procedimiento para su preparacion.
BG103325A (en) Analgetic preparation for external application
DK0727996T3 (da) Fendazolformuleringer
DK0599914T3 (da) Farmakologiske forbedrede formuleringer
RU95106653A (ru) Производные 2-имидазолин-5-онов и 2-имидазолин-5-тионов и фунгицидные композиции на их основе
CA2094090A1 (en) Thixotropic formulations
IE831863L (en) Fatty acid compositions.
ES511730A0 (es) "un procedimiento para la preparacion de oxaprocin calcico".
AR240400A1 (es) Procedimiento para obtener nuevas composiciones sinergicas para uso veterinario.
EP0113009A3 (de) Antimykotische Mittel mit hoher Wirkstoff-Freisetzung in Form von Gelsystemen
IT1291895B1 (it) Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
AR008474A1 (es) Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso
DK452788A (da) Smertestillende praeparat
SU1282736A1 (ru) Фотоинициатор для композиций сухих пленочных фоторезистов